drugset / Trial / NCT00143273
Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To establish the optimal dose of lasofoxifene that is fully effective in increasing the BMD in postmenopausal Asian women.
Timeline
- Start
- 2004-06
- Primary completion
- 2006-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lasofoxifene | Small molecule | 0.05 mg | — |
| Subject | Lasofoxifene | Small molecule | 0.25 mg | — |
| Subject | Lasofoxifene | Small molecule | 0.5 mg | — |